EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analytical Strategies for the Determination of Dapagliflozin in Pharmaceutical and Biological Matrices: A Comprehensive Review

Ecaterina Gliga, Denisa Gabriela Stroia, Gabriel Hancu, Eleonora Mircia

Scientia Pharmaceutica · 14.07.2026 · 94 (3) · 59

DOI: 10.3390/scipharm94030059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientia Pharmaceutica, online erschienen am 14.07.2026. Verfasst von Ecaterina Gliga und 3 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dapagliflozin (DAPA), a selective sodium–glucose cotransporter 2 inhibitor, is widely used in the management of type 2 diabetes mellitus, with additional indications in heart failure and chronic kidney disease. The growing analytical demand for DAPA determination in pharmaceutical formulations, fixed-dose combinations, and biological matrices has stimulated the development of diverse analytical methods. This review provides a comprehensive evaluation of reported techniques for DAPA quantification in different matrices. Approaches discussed include chromatographic methods (TLC, RP-HPLC, UHPLC, LC-MS/MS), electromigration techniques (CE), and spectroscopic methods (UV–Vis, spectrofluorimetry). Emphasis is placed on key performance characteristics such as selectivity, sensitivity, linearity, robustness, and applicability to stability studies and bioanalysis. Recent trends, including the application of Quality by Design, green analytical chemistry principles, and advanced hyphenated techniques, are also addressed. While RP-HPLC remains widely used for routine quality control due to its robustness and accessibility, LC-MS/MS is generally regarded as the method of choice for trace-level bioanalysis owing to its superior sensitivity and selectivity. CE and spectroscopic techniques offer cost-effective and environmentally friendly alternatives, though with certain limitations. This review highlights current methodological gaps and outlines future directions for developing more sensitive and sustainable analytical strategies.

Zitieren

APA

Gliga, E., Stroia, D. G., Hancu, G., & Mircia, E. (2026). Analytical Strategies for the Determination of Dapagliflozin in Pharmaceutical and Biological Matrices: A Comprehensive Review. Scientia Pharmaceutica, 94(3), 59. https://doi.org/10.3390/scipharm94030059

Vancouver

Gliga E, Stroia DG, Hancu G, Mircia E. Analytical Strategies for the Determination of Dapagliflozin in Pharmaceutical and Biological Matrices: A Comprehensive Review. Scientia Pharmaceutica. 2026;94(3):59. doi:10.3390/scipharm94030059

BibTeX
@article{Gliga2026,
  author = {Gliga, Ecaterina and Stroia, Denisa Gabriela and Hancu, Gabriel and Mircia, Eleonora},
  title = {Analytical Strategies for the Determination of Dapagliflozin in Pharmaceutical and Biological Matrices: A Comprehensive Review},
  journal = {Scientia Pharmaceutica},
  year = {2026},
  volume = {94},
  number = {3},
  pages = {59},
  doi = {10.3390/scipharm94030059}
}
Kostenlos starten →